共 4 条
[1]
Incidence; risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single‐centre experience in 303 patients[J] KostasZervas;EvgeniaVerrou;ZisisTeleioudis;KonstantinosVahtsevanos;AnastasiaBanti;DimitraMihou;DimitrisKrikelis;EvangelosTerpos British Journal of Haematology 2006,
[2]
Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors; Recognition; Prevention; and Treatment[J] Robert E. Marx;Yoh Sawatari;Michel Fortin;Vishtasb Broumand Journal of Oral and Maxillofacial Surgery 2005,
[3]
Rapid administration of ibandronate does not affect renal functioning: evidence from clinical studies in metastatic bone disease and hypercalcaemia of malignancy[J] M. Pecherstorfer;I. J. Diel Supportive Care in Cancer 2004,
[4]
Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic[J] Robert E Marx Journal of Oral and Maxillofacial Surgery 2003,